# D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights

> **NCT01037101** · NA · UNKNOWN · sponsor: **CAMC Health System** · enrollment: 80 (estimated)

## Conditions studied

- Height Phobia

## Interventions

- **BEHAVIORAL:** In Vivo Exposure Therapy
- **BEHAVIORAL:** Virtual Reality Exposure Therapy
- **DRUG:** D-Cycloserine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01037101
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-10-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037101, "D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01037101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*